Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Positive On FDA's Direct-to-Consumer Advertising Guidances

This article was originally published in The Pink Sheet Daily

Executive Summary

The Federal Trade Commission suggests that FDA should research consumer comprehension of risk information in print ads. The commission affirms its jurisdiction over "disease awareness" ads that do not mention a specific drug.
Advertisement

Related Content

FDA Extends Comment Period For Direct-To-Consumer Advertising Guidances
FDA Extends Comment Period For Direct-To-Consumer Advertising Guidances
FDA "Brief Summary" Changes Should Be Written In Regs - PhRMA
Alternatives To Brief Summary Outlined In Draft Guidance
Alternatives To Brief Summary Outlined In Draft Guidance

Topics

Advertisement
UsernamePublicRestriction

Register

PS059399

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel